Medicare Enrolled

Dr. David Heiman, M.D.

Gastroenterology · Tampa, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
4224 N TAMPANIA AVE, Tampa, FL 33607
8132807111
In practice since 2005 (20 years)
NPI: 1750385407 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Heiman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Heiman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Heiman

Dr. David Heiman is a gastroenterology in Tampa, FL, with 20 years in practice. Based on federal Medicare data, Dr. Heiman performed 1,267 Medicare services across 884 unique beneficiaries.

Between the years covered by Open Payments, Dr. Heiman received a total of $16,973 from 57 pharmaceutical and/or device companies across 891 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Heiman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 24% volume in FL$ $16,973 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,267
Medicare services
Top 24% in FL for gastroenterology
884
Unique beneficiaries
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~63 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)370$65$186
Hospital follow-up visit, moderate complexity286$63$186
Office visit, established patient (30-39 min)185$91$273
New patient office visit (45-59 min)100$121$415
Hospital follow-up visit, low complexity71$40$101
Initial hospital admission, moderate complexity67$103$350
Removal of polyps or growths of large bowel using an endoscope with mechanical snare51$207$1,104
Colorectal cancer screening; colonoscopy on individual at high risk42$181$817
Upper GI endoscopy with biopsy25$74$896
New patient office visit (30-44 min)23$61$273
Colonoscopy with biopsy19$112$1,044
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk16$183$818
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope12$73$672
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,973
Total received (2018-2024)
Avg $2,425/year across 7 years
Top 9% in FL for gastroenterology
57
Companies
891
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,601 (97.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$338 (2.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$34 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,360
2023
$2,420
2022
$2,984
2021
$3,190
2020
$1,763
2019
$2,118
2018
$2,139

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$2,346
ABBVIE INC.
$2,197
Takeda Pharmaceuticals U.S.A., Inc.
$2,135
Janssen Biotech, Inc.
$1,372
AbbVie Inc.
$1,148
Gilead Sciences, Inc.
$902
AbbVie, Inc.
$861
RedHill Biopharma Inc.
$677
Celgene Corporation
$562
VIVUS LLC
$399
Nestle HealthCare Nutrition Inc.
$378
Merck Sharp & Dohme LLC
$346
PFIZER INC.
$294
Ironwood Pharmaceuticals, Inc
$271
Allergan Inc.
$216
Merck Sharp & Dohme Corporation
$211
QOL Medical, LLC
$196
Lilly USA, LLC
$193
Intercept Pharmaceuticals, Inc.
$183
UCB, Inc.
$181
IRONWOOD PHARMACEUTICALS, INC
$175
INTRA-SANA LABORATORIES
$128
INTERCEPT PHARMACEUTICALS, INC.
$120
Synergy Pharmaceuticals Inc
$116
GENZYME CORPORATION
$107
Phathom Pharmaceuticals, Inc.
$102
Celltrion USA Inc.
$100
NESTLE HEALTHCARE NUTRITION INC.
$94
EVOKE PHARMA, INC.
$87
Fresenius Kabi USA, LLC
$65
Romark Laboratories, LC
$64
Endo Pharmaceuticals Inc.
$63
Ferring Pharmaceuticals Inc.
$55
Regeneron Healthcare Solutions, Inc.
$50
STERIS CORPORATION
$50
Concordia Pharmaceuticals Inc.
$50
AIMMUNE THERAPEUTICS, INC.
$44
Madrigal Pharmaceuticals
$44
VIVUS, Inc.
$40
Shire North American Group Inc
$31
Janssen Scientific Affairs, LLC
$29
Ardelyx, Inc.
$28
Pharming Healthcare, Inc.
$24
Dynavax Technologies Corporation
$24
Genentech USA, Inc.
$20
Allergan, Inc.
$20
Daiichi Sankyo Inc.
$20
Digestive Care, Inc.
$20
Lucid Diagnostics Inc.
$19
ALCRESTA THERAPEUTICS, INC.
$17
Evoke Pharma, Inc.
$16
Otsuka America Pharmaceutical, Inc.
$15
Amgen Inc.
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Exact Sciences Corporation
$14
Alfasigma USA, Inc.
$13
Ethicon US, LLC
$13
Top 3 companies account for 39.4% of total payments
Associated products mentioned in payments ›
ALINIA · APRISO · AVSOLA · Aemcolo · Alinia Tablets 500mg 30 count bottle · Amitiza · Avastin · BREATHTEK · CLENPIQ · CREON · CYLTEZO · Cimzia · Cologuard Collection Kit · Creon · DIFICID · DONNATAL · DUPIXENT · Dexilant · Donnatal · ENTYVIO · Entyvio · Epclusa · GATTEX · GIMOTI · HUMIRA · Heplisav-B · Humira · IBSRELA · IDACIO · INFLECTRA · INJECTAFER · LINX Reflux Management System · LINZESS · Linzess · MOTEGRITY · Mavyret · Motegrity · Movantik · NASCOBAL · OCALIVA · OMVOH · PANCREAZE · PLENVU · Pancreaze · Pertzye · REBYOTA · RELISTOR · RELIZORB · RELTONE 200 MG · REMICADE · RESMETIROM · RINVOQ · RUCONEST · SKYRIZI · STELARA · SUCRAID · Sucraid · TREMFYA · TRULANCE · Talicia · Trulance · VIBERZI · VOQUEZNA · VOWST · XELJANZ · XIFAXAN · XIFAXANIBSD · XIFIXAN · ZENPEP · ZEPOSIA · ZYMFENTRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for gastroenterology in FL.

Equivalent to $1,340 per 100 Medicare services performed
Looking for a gastroenterology in Tampa?
Compare gastroenterologys in the Tampa area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
173
Per 100K population
11.6
County median income
$75,011
Nearest hospital
ST JOSEPHS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Heiman is a clinical cardiology specialist, with above-average Medicare volume (top 24% in FL), and high industry engagement (low-engagement, top 9%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Heiman experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Heiman performed 370 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Heiman receive payments from pharmaceutical companies?
Yes. Dr. Heiman received a total of $16,973 from 57 companies across 891 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Heiman's costs compare to other gastroenterologys in Tampa?
Dr. Heiman's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Heiman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →